(3) For advanced-stage patients or whose tumor is surgically unresectable, if they ever received chemoradiotherapy or radiotherapy, PD-1 inhibitors could significantly prolong the OS, and Pembrolizumab may be better than Nivolumab. The gene discussed is PDCD1; the disease is neoplasm.